Supplemental Material - Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis

Published: 18 April 2024| Version 1 | DOI: 10.17632/vwycbkk9x2.1
Contributor:
Waliul Khan

Description

Supplementary Material for the paper entitled "Novel 5-HT7 receptor antagonists modulate intestinal immune responses and reduce severity of colitis" by Kwon et al.

Files

Institutions

McMaster University

Categories

Inflammatory Bowel Disease, Serotonin Receptor Affecting Agent, Serotonin

Funding

Canadian Institutes of Health Research

PJT156262

Crohn's and Colitis Foundation

510490

Licence